DEI Bureaucrat Watch List

DOSSIER

A quick summary of DEI offenses

Christine Burgess

Salary:
$153,434
Grade:
GS-15
National Institutes of Health
Health Scientist Administrator - NIC

Christine Burgess's

Partisan Political Activities

She is a serial political donor who gave to the Radical Left.

Bob Casey For Senate-7/15/24-$25

Harris For President-7/21/24-$46

Harris For President-9/11/24-$47

Harris For President-8/22/24-$40

Biden For President-6/19/24-$100

Jamie Harrison For US Senate-9/22/20-$15

Biden Victory Fund-10/21/20-$15

Biden For President -9/29/20-$15

Kamala Harris For The People-5/21/19-$20.2

(Source)

As OpenSecrets notes, "Only a tiny fraction of Americans actually give campaign contributions to political candidates, parties or PACs. Just 0.97% of the United States population contributed more than two hundred dollars to federal candidates, PACs, parties, and outside groups [lastcycle]"  This is the reason campaign contributions are such an instructive tool in analyzing civil servants, because only the most avid partisans - less than one percent - write a check to a candidate.

Christine Burgess's

Notable Financial Relationships

Christine Burgess's

Notable Prior Employment History

February 2020-Present-National Cancer Institute (NCI)-Health Scientist Administrator

July 2018-February 2020-Digital Science-Senior Director, Research Analytics

August 2017-June 2018-Clarivate Analytics-Managing Consultant

January 2016-August 2017-Clarivate Analytics-Scientific Analyst

December 2011-January 2016-AAAS-Project Director in the Research Competitiveness Program

2010-2011-Westfälische Wilhems-Universität-Alexander von Humboldt Postdoctoral Fellow

2007-2009-Princeton University-Graduate Fellow

2005-2009-Princeton University-Assistant In Instruction

2004-2009-Princeton University-Graduate Research Assistant

(Source)

Pushing Equity At NCI

Christine Burgess, through her work at the National Cancer Institute,  is pushing a left-wing agenda of equity in cancer research, focusing on racial and ethnic demographics rather than scientific merit. This approach could misallocate vital research funds, potentially diverting attention and resources from areas where they could benefit all cancer patients regardless of race.

(Source)